Clinical Trials Directory

Trials / Suspended

SuspendedNCT06239493

IVUS-Guided Treatment for Percutaneous Vascular Interventions

Status
Suspended
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Philips Clinical & Medical Affairs Global · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to survey and improve the IVUS image quality and X-ray system interoperability by collecting Procedural Data (e.g. raw, pre- processed ultrasound and X-ray data, endpoints such as fluoroscopy time, contrast load and radiation dose, workflow details) during routine intravascular procedures to assure adherence to the high standards of quality during care delivery and promote procedural standardization.

Detailed description

This is a prospective, multicenter, single-arm study to collect procedural data (e.g., raw, pre-processed IVUS, X-ray, and other procedural data) for image quality, workflow and interoperability assessments. Example of additional procedural endpoint data (e.g., time for fluoroscopy and IVUS, contrast load and radiation dose, workflow details, etc.) will be collected. The study will be conducted in a phased approach. Since the collection of IVUS raw data with a second non-diagnostic pullback affects procedure time, the two aspects of this study - collection of raw IVUS data and procedural data, will be separated until IVUS raw data can be collected directly from the IVUS system with no additional procedural time.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIVUS GuidedThose already undergoing an IVUS guided percutaneous vascular intervention

Timeline

Start date
2023-09-14
Primary completion
2028-02-01
Completion
2028-02-01
First posted
2024-02-02
Last updated
2025-05-31

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06239493. Inclusion in this directory is not an endorsement.